Author:
Perifanis Vassilios,Christoforidis Athanasios,Vlachaki Efthimia,Tsatra Ioanna,Spanos George,Athanassiou-Metaxa Miranda
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia.Ann N Y Acad Sci. 2005;1054:40–47.
2. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR, and the Thalassemia Clinical Research Network. Complications of β-thalassemia major in North America.Blood. 2004;104:34–39.
3. Piga A, Gaglioti C, Fogliacco E,Tricta F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis.Haematologica. 2003;88:489–496.
4. Glickstein H, El RB, Shvartsman M, Cabantchik ZI. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells.Blood. 2005;106:3242–3250.
5. Link G, Konijn AM, Breuer W, Cabantchik ZI, Hershko C. Exploring the “iron shuttle” hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.J Lab Clin Med. 2001;138:130–138.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献